We are live on
!
Find out more
SCM
Stevens Capital Management Portfolio holdings
AUM
$649M
1-Year Est. Return
27.37%
This Fund
S&P 500
This Quarter
Est. Return
+2.44%
1 Year Est. Return
+27.37%
3 Year Est. Return
+49.81%
5 Year Est. Return
+67%
10 Year Est. Return
+208.35%
AUM
$2.24B
AUM Growth
-$107M
(-4.6%)
Cap. Flow
-$138M
Cap. Flow
% of AUM
-6.17%
Top 10 Holdings %
Top 10 Hldgs %
13.17%
Holding
955
New
308
Increased
134
Reduced
160
Closed
350
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$31.3M |
| 2 |
Merck
MRK
|
+$28.9M |
| 3 |
Morgan Stanley
MS
|
+$28.2M |
| 4 |
Verizon
VZ
|
+$27.6M |
| 5 |
Johnson & Johnson
JNJ
|
+$23.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CME Group
CME
|
+$22.4M |
| 2 |
Duke Energy
DUK
|
+$22M |
| 3 |
Cognizant
CTSH
|
+$19.2M |
| 4 |
Fidelity National Information Services
FIS
|
+$19M |
| 5 |
Eaton
ETN
|
+$18.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 16.11% |
| 2 | Healthcare | 14.85% |
| 3 | Industrials | 13.1% |
| 4 | Technology | 12.1% |
| 5 | Consumer Discretionary | 9.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
476
EPAM Systems
EPAM
$5.58B
| $445K | 0.02% |
+2,573
| New | +$443K |
|
477
Idacorp
IDA
$8B
| $445K | 0.02% |
+4,434
| New | +$447K |
|
478
Coca-Cola Femsa
KOF
$22.5B
| $444K | 0.02% |
+7,151
| New | +$458K |
|
479
Ulta Beauty
ULTA
$21.8B
| $443K | 0.02% |
1,277
-24,719
| -95% | -$8.54M |
|
480
Santander
BSBR
$38.2B
| $442K | 0.02% |
+38,866
| New | +$422K |
|
481
Sea Limited
SE
$66.4B
| $441K | 0.02% |
+13,267
| New | +$360K |
|
482
Nu Skin
NUS
$257M
| $439K | 0.02% |
+8,891
| New | +$452K |
|
483
The Greenbrier Companies
GBX
$1.57B
| $438K | 0.02% |
+14,411
| New | +$458K |
|
484
Spire
SR
$4.79B
| $435K | 0.02% |
5,184
+37
| +0.7% | +$3.1K |
|
485
John Wiley & Sons Class A
WLY
$2.83B
| $430K | 0.02% |
+9,369
| New | +$426K |
|
486
CNO Financial Group
CNO
$4.94B
| $429K | 0.02% |
+25,742
| New | +$426K |
|
|
PRSP
487
DELISTED
Perspecta Inc. Common Stock
PRSP
| $428K | 0.02% |
+18,293
| New | +$411K |
|
488
Cemex
CX
$16.9B
| $427K | 0.02% |
100,604
+54,959
| +120% | +$245K |
|
|
GLIBA
489
DELISTED
GCI Liberty, Inc. Class A Common Stock (DE)
GLIBA
| $414K | 0.02% |
+6,739
| New | +$400K |
|
490
SK Telecom
SKM
$11.4B
| $411K | 0.02% |
10,090
+3,568
| +55% | +$142K |
|
|
CORE
491
DELISTED
Core Mark Holding Co., Inc.
CORE
| $408K | 0.02% |
10,276
+1,865
| +22% | +$70.1K |
|
|
NUVA
492
DELISTED
NuVasive, Inc.
NUVA
| $406K | 0.02% |
+6,943
| New | +$410K |
|
|
BBL
493
DELISTED
BHP Group Plc American Depositary Shares (Each representing two Ordinary Shares)
BBL
| $406K | 0.02% |
7,947
-1,649
| -17% | -$78.8K |
|
494
Grupo Aeroportuario del Pacifico
PAC
$12.9B
| $405K | 0.02% |
+3,878
| New | +$393K |
|
495
Four Corners Property Trust
FCPT
$2.89B
| $401K | 0.02% |
14,683
+6,405
| +77% | +$183K |
|
496
T-Mobile US
TMUS
$195B
| $386K | 0.02% |
5,206
-5,935
| -53% | -$441K |
|
497
Consolidated Edison
ED
$41.4B
| $383K | 0.02% |
4,367
-6,331
| -59% | -$545K |
|
|
WPX
498
DELISTED
WPX Energy, Inc.
WPX
| $380K | 0.02% |
32,989
-283,158
| -90% | -$3.52M |
|
499
SITE Centers
SITC
$236M
| $377K | 0.02% |
36,466
-73,298
| -67% | -$769K |
|
500
Marcus Corp
MCS
$767M
| $376K | 0.02% |
+11,397
| New | +$419K |
|
Similar funds
CCA
GAMA
TWP
ACA
CAAM
RK
PCM
ITC
Stevens Capital Management's Q2 2019 Portfolio in Review
As of Q2 2019, Stevens Capital Management held 955 positions worth $2.24B, down 4.6% from $2.34B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Stevens Capital Management withdrew a net $138M in Q2 2019, closing 350 positions and reducing 160 holdings. Its most notable exit was Cognizant, an estimated $19.2M position sold in full.
By sector, the portfolio is most concentrated in Financials at 16% of assets, up from 15% a quarter earlier, followed by Healthcare and Industrials.
Against the trend, Stevens Capital Management opened a new position in Merck worth $30.2M.
- Stevens Capital Management's largest Q2 2019 buy was Merck: 377,581 shares worth $30.2M.
- Stevens Capital Management added most to Eli Lilly in Q2 2019, an estimated $31.3M increase.
- Stevens Capital Management's biggest Q2 2019 reduction was CME Group, cutting an estimated $22.4M.
- Stevens Capital Management fully exited Cognizant in Q2 2019, selling an estimated $19.2M.
- Stevens Capital Management's ten largest holdings make up 13% of its $2.24B portfolio in Q2 2019.
- Stevens Capital Management opened 308 new positions and closed 350 in Q2 2019.
- Stevens Capital Management's portfolio value fell 4.6% quarter-over-quarter to $2.24B.
Based on Stevens Capital Management's 13F filing for Q2 2019, filed 31 Jul 2019.